The GLP is committed to full transparency. Download and review our 2019 Annual Report

3-10-2019 jacob plieth vantage

US approves immunotherapy for breast cancer for first time

Roche’s cancer immunotherapy Tecentriq (atezolizumab), a PD-L1 inhibitor, scored its fifth Food and Drug Administration approval on [March 8], for advanced triple-negative ...
chain of paper people

This small startup wants to change FDA clinical trials by making control groups unnecessary

Could a startup founded by two guys in their 20s change the way medical researchers study patients? The Food and ...